Changes related to "Cisplatin (Platinol)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 21:02, 20 June 2018
   
Page name:

20 June 2018

     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   14:53  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+491). . [Jwarner‎ (3×)]
 m    14:53 (cur | prev) . . (+213). . Jwarner (talk | contribs)
 m    13:43 (cur | prev) . . (+2,393). . Jwarner (talk | contribs) (R-DHAP {{#subobject:18c266|Regimen=1}})
 m    13:37 (cur | prev) . . (-2,115). . Jwarner (talk | contribs) (ROAD {{#subobject:0d0c67|Regimen=1}})
 m   11:57  Mantle cell lymphoma‎ (diff | hist) . . (+105). . Jwarner (talk | contribs)
 m   11:42  Uterine cancer‎ (diff | hist) . . (+30). . Jwarner (talk | contribs)
 m   11:24  Extranodal NK/T-cell lymphoma, nasal type‎ (diff | hist) . . (+38). . Jwarner (talk | contribs) (LVP {{#subobject:1ba9b6|Regimen=1}})
 m   11:11  Multiple myeloma‎ (diff | hist) . . (+6). . Jwarner (talk | contribs)
 m   10:46  Esophageal cancer‎ (diff | hist) . . (+180). . Jwarner (talk | contribs) (FOLFOX-C {{#subobject:e51095|Regimen=1}})

19 June 2018

 m   23:01  Esophageal cancer‎ (diff | hist) . . (-35). . Jwarner (talk | contribs)
 m   22:39  Pancreatic cancer‎‎ (2 changes | history) . . (+186). . [Jwarner‎ (2×)]
 m    22:39 (cur | prev) . . (+72). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:34e70d|Regimen=1}})
 m    22:38 (cur | prev) . . (+114). . Jwarner (talk | contribs)
 m   17:41  Gastric cancer‎ (diff | hist) . . (+21). . Jwarner (talk | contribs) (ECC {{#subobject:36cac7|Regimen=1}})
 m   17:29  Ovarian cancer‎ (diff | hist) . . (+66). . Jwarner (talk | contribs) (Relapsed or recurrent disease, platinum-resistant)
 m   17:26  Extranodal NK/T-cell lymphoma, nasal type‎ (diff | hist) . . (+108). . Jwarner (talk | contribs)
 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   11:26  Multiple myeloma‎ (diff | hist) . . (+1,082). . Jwarner (talk | contribs)

18 June 2018

     23:14  Esophageal cancer‎‎ (6 changes | history) . . (+3,152). . [Jwarner‎ (2×); Nainasingh‎ (4×)]
 m    23:14 (cur | prev) . . (+149). . Jwarner (talk | contribs)
 m    22:00 (cur | prev) . . (+9). . Jwarner (talk | contribs) (Capecitabine, Paclitaxel, RT {{#subobject:17bbec|Regimen=1}})
      18:41 (cur | prev) . . (+1,269). . Nainasingh (talk | contribs) (Regimen  ) (Tag: Visual edit)
      18:09 (cur | prev) . . (+635). . Nainasingh (talk | contribs) (Regimen  ) (Tag: Visual edit)
      17:50 (cur | prev) . . (+1,066). . Nainasingh (talk | contribs) (Variant #1  ) (Tag: Visual edit)
      17:10 (cur | prev) . . (+24). . Nainasingh (talk | contribs) (Chemotherapy) (Tag: Visual edit)
 m   23:05  Mesothelioma‎ (diff | hist) . . (+82). . Jwarner (talk | contribs) (Advanced or metastatic disease, first-line therapy)
 m   22:52  Nasopharyngeal carcinoma‎‎ (2 changes | history) . . (+9). . [Jwarner‎ (2×)]
 m    22:52 (cur | prev) . . (+8). . Jwarner (talk | contribs) (Locally advanced disease, induction)
 m    22:52 (cur | prev) . . (+1). . Jwarner (talk | contribs)
 m   22:49  Head and neck cancer‎ (diff | hist) . . (0). . Jwarner (talk | contribs)
 m   22:46  Penile cancer‎‎ (3 changes | history) . . (+57). . [Jwarner‎ (3×)]
 m    22:46 (cur | prev) . . (+23). . Jwarner (talk | contribs) (Metastatic or unresectable disease)
 m    22:45 (cur | prev) . . (0). . Jwarner (talk | contribs) (Adjuvant chemotherapy)
 m    22:44 (cur | prev) . . (+34). . Jwarner (talk | contribs) (Adjuvant chemotherapy)
 m   22:40  SCC of unknown primary‎ (diff | hist) . . (+142). . Jwarner (talk | contribs) (All lines of therapy)
     22:33  Small cell lung cancer‎‎ (3 changes | history) . . (+5,328). . [Jwarner‎ (3×)]
      22:33 (cur | prev) . . (+5,674). . Jwarner (talk | contribs) (Limited stage, consolidation)
 m    22:32 (cur | prev) . . (-437). . Jwarner (talk | contribs) (Limited stage, definitive chemoradiotherapy)
 m    22:16 (cur | prev) . . (+91). . Jwarner (talk | contribs) (Limited stage, induction)
 m   20:56  Hodgkin lymphoma‎‎ (2 changes | history) . . (+148). . [Jwarner‎ (2×)]
 m    20:56 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Subsequent treatment)
 m    20:55 (cur | prev) . . (+144). . Jwarner (talk | contribs) (Consolidation after upfront therapy)
 m   17:42  Multiple myeloma‎‎ (5 changes | history) . . (-83). . [Jwarner‎ (5×)]
 m    17:42 (cur | prev) . . (-94). . Jwarner (talk | contribs)
 m    17:41 (cur | prev) . . (+3,384). . Jwarner (talk | contribs) (VT {{#subobject:e94510|Regimen=1}})
 m    17:37 (cur | prev) . . (-3,293). . Jwarner (talk | contribs) (Bortezomib & Prednisone {{#subobject:ee2988|Regimen=1}})
 m    17:13 (cur | prev) . . (+2,087). . Jwarner (talk | contribs) (PAD {{#subobject:955a56|Regimen=1}})
 m    16:58 (cur | prev) . . (-2,167). . Jwarner (talk | contribs) (BDD {{#subobject:6ab815|Regimen=1}})
 m   17:29  Adenocarcinoma of unknown primary‎ (diff | hist) . . (+56). . Jwarner (talk | contribs) (Bleomycin, Cisplatin, Etoposide {{#subobject:cc3566|Regimen=1}})

17 June 2018

 m   22:06  Squamous cell carcinoma (SCC)‎ (diff | hist) . . (+66). . Jwarner (talk | contribs) (Cetuximab monotherapy {{#subobject:5f3411|Regimen=1}})
 m   21:46  Non-small cell lung cancer‎‎ (2 changes | history) . . (+1,659). . [Jwarner‎ (2×)]
 m    21:46 (cur | prev) . . (+813). . Jwarner (talk | contribs) (Cisplatin & Gemcitabine {{#subobject:fb3ee0|Regimen=1}})
 m    20:49 (cur | prev) . . (+846). . Jwarner (talk | contribs) (Carboplatin & Paclitaxel {{#subobject:c5fbdf|Regimen=1}})